As a key negative feedback regulator, IL-10 prevents the onset and progression of liver fibrosis by inhibition the release of inflammatory mediator, suppressing NF-κB activity, and acting through other mechanisms to protect the liver. Here, NFKB1 is linked to Hepatic fibrosis.